文献速递血液透析通路

动脉瘤性动静脉瘘修复的系统评价与Meta分析

Repair of Aneurysmal Arteriovenous Fistulae: A Systematic Review and Meta-analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2019-12-24

该系统评价与Meta分析纳入13项研究共597例患者,评估动脉瘤性动静脉瘘的外科治疗选项。动脉瘤修复术是全部13项研究中的首选术式,12个月汇总一期通畅率为82%(95%CI 69%-90%)。结论认为动脉瘤修复术短期和长期结果可接受,并发症和动脉瘤复发率低。

要点

  • 动脉瘤修复术是动脉瘤性动静脉瘘的首选外科术式,12个月汇总一期通畅率82%。
  • 最常见治疗指征为预防出血,占513例(86%)。
  • 动脉瘤位于上臂者289例(59%),接受治疗的最小动脉瘤直径为15 mm。

核心结论

  • 动脉瘤性动静脉瘘的动脉瘤修复术短期和长期结果可接受,并发症和动脉瘤复发率低。

研究设计与样本

  • 系统评价与Meta分析,检索1973年1月至2019年3月发表的描述动静脉瘘动脉瘤外科治疗的文章。
  • 共识别794条记录,去除重复和低质量研究后审查72篇全文,最终13篇纳入Meta分析,总患者数597例。

主要发现

  • 动脉瘤位于上臂者289例(59%),接受治疗的最小动脉瘤直径为15 mm。
  • 最常见治疗指征为预防出血,513例(86%)。
  • 动脉瘤修复术在全部13项研究中均为首选手术方法。
  • 12个月汇总一期通畅率为82%(95%CI 69%-90%,12项研究,I2=84%,p<.01)。
  • 12个月一期通畅率在外部人工血管补片加强的动脉瘤修复术(85%,95%CI 71%-93%,2项研究,I2=0%,p=.33)、使用吻合器的动脉瘤修复术(74%,95%CI 61%-83%,4项研究,I2=0%,p=.48)与不使用吻合器者(82%,95%CI 60%-94%,6项研究,I2=92%,p<.01)之间相似。

临床怎么用

  • 对于动脉瘤性动静脉瘘,可考虑动脉瘤修复术作为外科治疗选择,其12个月一期通畅率约82%。
  • 预防出血是动脉瘤性动静脉瘘最常见的治疗指征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Aneurysms arising from arteriovenous fistulae are a common finding among dialysed patients and pose a risk of acute bleeding. The aim of this study was to perform a systematic review and meta-analysis evaluating the surgical options for the treatment of aneurysmal arteriovenous fistulae. METHODS: A systematic review and meta-analysis of articles published between January 1973 and March 2019 describing the surgical treatment of arteriovenous fistulae aneurysms. RESULTS: A total of 794 records were identified. After duplicate and low quality studies were removed, 72 full text articles were reviewed and from these 13 were included in the meta-analysis. The total number of patients was 597. Aneurysms were located in the upper arm in 289 (59%) cases and the smallest diameter of a treated aneurysm was 15 mm. The most frequent indication for treatment was bleeding prevention in 513 (86%) cases. Aneurysmorrhaphy was the surgical method of choice in all 13 studies. The pooled primary patency at 12 months was 82% (95% CI 69%-90%, 12 studies, I2 = 84%, p < .01). The 12 month primary patency rates were similar for aneurysmorrhaphy with external prosthetic reinforcement (85%, 95% CI 71%-93%, two studies, I2 = 0%, p = .33) and aneurysmorrhaphy performed using a stapler (74%, 95% CI 61%-83%, four studies, I2 = 0%, p = .48) and without a stapler (82%, 95% CI 60%-94%, six studies, I2 = 92%, p < .01). CONCLUSION: Aneurysmorraphy of arteriovenous fistulae is a procedure with acceptable short and long term results, with a low complication and aneurysm recurrence rate.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Baláž P, Rokošný S, Bafrnec J, et al. Repair of Aneurysmal Arteriovenous Fistulae: A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg. 2019. PMID: 31879147. doi:10.1016/j.ejvs.2019.07.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。